Schedule 13G ownership disclosure
NeuBase Therapeutics, Inc.
Security class unavailable · CUSIP: 64132K102
Event date: 2022-12-29
Legacy cover-page extraction is best effort and may not include every reporting person.
- Filing-level shares
- 1,497,226
- Percent of class
- 4.4600%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001535384-23-000001
- Form type
- SC 13G
- Filer
- Kershner Trading Americas,LLC
- CIK
- CIK 1535384
- Filed
- Jan 27, 2023
- Reporting period
- Dec 29, 2022
- Description
- Schedule 13G beneficial ownership